Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children

BACKGROUND: Abacavir and lamivudine are approved for once-daily use in HIV-infected adults. Limited pharmacokinetic (PK) data for abacavir and lamivudine in children are available. METHODS: A crossover study to compare PK of once- versus twice-daily abacavir and lamivudine was conducted in virologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunupuradah, Torsak, Punyahotra, Passorn, Cressey, Tim R, Srimuan, Amornrat, Thammajaruk, Narukjaporn, Sophonphan, Jiratchaya, Sriheara, Chulalak, Burger, David M, Puthanakit, Thanyawee, Ananworanich, Jintanat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946738/
https://www.ncbi.nlm.nih.gov/pubmed/27482411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946738/
https://www.ncbi.nlm.nih.gov/pubmed/27482411

Ejemplares similares